Skip to content
The Nexus
DossierENTITY

Marcus Luttrell

Coverage of Marcus Luttrell in the Nexus archive.

Earliest in view: Apr 18 · 14:53 UTCMost recent: Apr 18 · 14:53 UTC
Co-mentioned in this coverage
Donald Trumpperson1Robert F. Kennedy Jr.person1Joe Roganperson1Food and Drug Administration (FDA)organization1National Institutes of Health (NIH)organization1ibogainetopic1post-traumatic stress disorder (PTSD)topic1
Recent coverage
  • HEALTHApr 18 · 14:53 UTCAP NEWS
    Trump signs order to speed review of psychedelics, including the controversial drug ibogaine

    President Donald Trump signed an executive order to accelerate the review of psychedelic drugs, including ibogaine, which is controversial due to safety risks but advocated for by veterans and conservative lawmakers. The FDA will fast-track approvals using national priority vouchers, marking the first time psychedelics receive such expedited review. The move aims to expand access to potential treatments for conditions like PTSD and opioid addiction.

Marcus Luttrell · Dossier · The Nexus